Abeona Therapeutics Inc. (ABEO) — DEF 14A Filings
All DEF 14A filings from Abeona Therapeutics Inc.. Browse 3 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (3)
-
Abeona Therapeutics DEF 14A: Executive Compensation Details
— Apr 9, 2025 Risk: medium
Abeona Therapeutics Inc. filed its DEF 14A on April 9, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing includes -
Abeona Therapeutics Files Definitive Proxy Statement
— Nov 12, 2024 Risk: medium
Abeona Therapeutics Inc. filed a definitive proxy statement (DEF 14A) on November 12, 2024. The filing pertains to the company's annual meeting and related matt -
Abeona Therapeutics Inc. Announces 2024 Annual Meeting of Stockholders
— Mar 19, 2024 Risk: low
ABEONA THERAPEUTICS INC. (ABEO) filed a Proxy Statement (DEF 14A) with the SEC on March 19, 2024. The Annual Meeting of Stockholders for Abeona Therapeutics Inc
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX